Nel ASA's European Assembly Bet Hinges on Orders That Have Yet to Materialize
Published on 09/18/2026 at 18:51 | Editorial boerse-global.de
Nel ASA finds itself caught between two clocks that run at very different speeds. One measures the slow grind of hydrogen project planning; the other tracks a share price that has been drifting near the bottom of its range. The Norwegian electrolyser maker is trying to bridge that gap by pushing assembly work closer to European customers — a strategy that looks tidy on paper but still lacks the one thing investors want most: signed orders.
The stock last changed hands at 0,1954 Euro, a level that captures the market's lingering caution. On a technical basis, the shares sit 9,6 percent below their 200-day moving average of 0,2128 Euro, while the 52-week low of 0,1731 Euro looms as the line that has so far prevented a deeper slide.
A Framework Deal Without a Number Attached
At the heart of Nel's European push is a framework agreement with Hydrasun, an arrangement that splits the production chain across two continents. The PEM stacks themselves will continue to roll out of Wallingford, Connecticut. Hydrasun, for its part, takes on procurement, manufacturing and the integration of the peripheral balance-of-plant systems on European soil.
That division of labour extends an integration structure Nel had already built in the United States, and it carries an obvious appeal: the company widens its delivery and integration reach in Europe without carrying the full industrial cost burden on its own balance sheet. What the agreement does not carry, according to the company, is a quantified order value or a binding purchase volume. Capacity and assembly lines are a logistical precondition for future deliveries — they do not, by themselves, generate revenue.
Where the Numbers Have Been Moving
The commercial picture is not uniformly bleak. In PEM electrolysers, revenue climbed 31 percent quarter on quarter to 97 million Norwegian kroner, powered largely by smaller kilowatt-scale systems. Management credited more efficient execution of existing customer projects for the margin improvement, and it is leaning deliberately on standardised smaller units to book near-term earnings while large-scale hydrogen schemes remain stuck in lengthy planning phases and postponed investment decisions.
Should investors sell immediately? Or is it worth buying Nel ASA?
Nel is also advancing its alkaline pressurised electrolyser platform, which was officially unveiled in May following prototype testing. Against those gains, a settlement with the Iwatani Corporation knocked 70 million kroner off the operating result in the same quarter. The agreement closed out litigation in the United States and reduced the risk of future legal costs — a meaningful uncertainty cleared, even if it dented the period's earnings.
The balance sheet offers room to manoeuvre. Nel reported liquid funds of 1.328 million kroner at the end of the second quarter. Chairman Arvid Moss put money behind his own conviction on 24 April, acquiring a total of 100.000 shares.
Leadership Void Adds to the Waiting Game
What investors cannot yet count on is a settled executive suite. Volldal will leave to become chief executive of Elopak ASA no later than the start of January 2027, and the board is still working through the search for a permanent successor. That limbo complicates the task of finalising large contracts and presenting the capital markets with a dependable strategic hand on the tiller.
It also sharpens the central question hanging over the Hydrasun arrangement. Until industrial customers place firm orders for the MC-series modular platform, the cooperation remains an operational skeleton. The upside case is straightforward enough: if demand for modular electrolysis systems picks up in Europe, Hydrasun can scale assembly independently, freeing Nel to concentrate on utilisation and scaling of stack production in Wallingford. Standardised stacks paired with external system integration would protect margins and make the business model less capital-hungry — the kind of dynamic investors would read as proof that the international expansion strategy is working.
The bear case is just as easy to sketch. Nel becomes dependent on a partner's processes and execution quality, and with no binding offtake commitments in place, any further delay in customer investment decisions drains the platform of its strategic value.
What to Watch From Here
Near term, the 52-week low of 0,1731 Euro is the level that matters. A hold there leaves room for stabilisation at a low altitude; a sustained break below it opens the door to another leg down. The next hard catalyst comes with the company's reporting schedule for the 2026 and 2027 financial years. Those quarterly dates will have to show whether the Hydrasun partnership is converting into binding customer orders. Until then, Nel ASA remains a stock where holders must weigh the absence of hard contracts against the theoretical promise of a European footprint.
Ad
Nel ASA Stock: New Analysis - 18 September
Fresh Nel ASA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
